Carcinoma of the penis primary prevention: Difference between revisions
Jump to navigation
Jump to search
Shanshan Cen (talk | contribs) No edit summary |
Shanshan Cen (talk | contribs) No edit summary |
||
| (9 intermediate revisions by 2 users not shown) | |||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Effective measures for the primary prevention of | Effective measures for the [[primary prevention]] of carcinoma of the penis include circumcision, good personal hygiene, and safer sexual practices. [[Gardasil]] [[vaccine]] is recommended for men to prevent [[HPV]] infection. | ||
==Primary Prevention== | ==Primary Prevention== | ||
Effective measures for the primary prevention of penile cancer include: | Effective measures for the primary prevention of penile cancer include:<ref>Cancer - penis. MedlinePlus 2015. https://www.nlm.nih.gov/medlineplus/ency/article/001276.htm </ref> | ||
* | * Circumcision | ||
* Good personal hygiene | * Good personal hygiene | ||
* Safer sexual practices | * Safer sexual practices such as: | ||
:* | :* Abstinence | ||
:* Limiting the number of sexual partners | |||
:* Use of condoms to prevent [[HPV]] infection | |||
* Vaccine | * Vaccine | ||
:* A quadri-valent vaccine to prevent HPV infection, [[Gardasil]], has been developed, successfully tested and approved for women by the US [[Food and Drug Administration]]. | :* A quadri-valent vaccine to prevent HPV infection, [[Gardasil]], has been developed, successfully tested and approved for women by the US [[Food and Drug Administration]].<ref name="pmid16918020">{{cite journal| author=Crum C, Jones C, Kirkpatrick P| title=Quadrivalent human papillomavirus recombinant vaccine. | journal=Nat Rev Drug Discov | year= 2006 | volume= 5 | issue= 8 | pages= 629-30 | pmid=16918020 | doi=10.1038/nrd2117 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16918020 }} </ref>Approval for men is expected in 2008. It is licensed and in production, and could substantially reduce the incidence of HPV infection in men, the incidence of genital warts and ano-genital cancers including penile cancer, and mortality.<ref name="pmid15541429">{{cite journal| author=Lehtinen M, Paavonen J| title=Vaccination against human papillomaviruses shows great promise. | journal=Lancet | year= 2004 | volume= 364 | issue= 9447 | pages= 1731-2 | pmid=15541429 | doi=10.1016/S0140-6736(04)17410-2 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15541429 }} </ref> | ||
==References== | ==References== | ||
Latest revision as of 14:06, 8 October 2015
|
Carcinoma of the penis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Carcinoma of the penis primary prevention On the Web |
|
American Roentgen Ray Society Images of Carcinoma of the penis primary prevention |
|
Risk calculators and risk factors for Carcinoma of the penis primary prevention |
Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Joel Gelman, M.D. [2], Director of the Center for Reconstructive Urology and Associate Clinical Professor in the Department of Urology at the University of California,Irvine
Overview
Effective measures for the primary prevention of carcinoma of the penis include circumcision, good personal hygiene, and safer sexual practices. Gardasil vaccine is recommended for men to prevent HPV infection.
Primary Prevention
Effective measures for the primary prevention of penile cancer include:[1]
- Circumcision
- Good personal hygiene
- Safer sexual practices such as:
- Abstinence
- Limiting the number of sexual partners
- Use of condoms to prevent HPV infection
- Vaccine
- A quadri-valent vaccine to prevent HPV infection, Gardasil, has been developed, successfully tested and approved for women by the US Food and Drug Administration.[2]Approval for men is expected in 2008. It is licensed and in production, and could substantially reduce the incidence of HPV infection in men, the incidence of genital warts and ano-genital cancers including penile cancer, and mortality.[3]
References
- ↑ Cancer - penis. MedlinePlus 2015. https://www.nlm.nih.gov/medlineplus/ency/article/001276.htm
- ↑ Crum C, Jones C, Kirkpatrick P (2006). "Quadrivalent human papillomavirus recombinant vaccine". Nat Rev Drug Discov. 5 (8): 629–30. doi:10.1038/nrd2117. PMID 16918020.
- ↑ Lehtinen M, Paavonen J (2004). "Vaccination against human papillomaviruses shows great promise". Lancet. 364 (9447): 1731–2. doi:10.1016/S0140-6736(04)17410-2. PMID 15541429.